Associated Papers
Innovative rapid screening for complex BCR-ABL1 kinase domain mutations in TKI-treated leukaemia patients.
Lan Y et al.
British Journal of Cancer, 2025
40588514 (PubMed )
Supplement: 41416_2025_3098_MOESM1_ESM.pdf
Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patients.
Dhangar S et al.
Leukemia Research, 2025
Detection of ABL1 kinase domain mutations in therapy-naïve BCR-ABL1-positive acute lymphoblastic leukemia.
Baer C et al.
Haematologica, 2022
34758608 (PubMed )
Supplement: 2021_279807_BAER_SUPPL.pdf
ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance.
Vacarean-Trandafir IC et al.
Molecular Biology Reports, 2019
Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and/or tyrosine kinase domain mutations.
Xue M et al.
International Journal of Laboratory Hematology, 2019
Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.
Kastner R et al.
European Journal of Cancer (oxford, England : 1990), 2014
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy.
Parker WT et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2011
Mutations in ABL kinase domain are associated with inferior progression-free survival.
Sharma P et al.
Leukemia & Lymphoma, 2010
Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA.
Ma W et al.
Leukemia, 2006
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.
Branford S et al.
Blood, 2002
Two different point mutations in ABL gene ATP-binding domain conferring Primary Imatinib resistance in a Chronic Myeloid Leukemia (CML) patient: A case report.
Iqbal Z et al.
Biological Procedures Online, 0
Select a paper to view details